Media

Category: Press

Filter by
Press
Dipharma SA
24 February 2019

Dipharma announces FDA acceptance of abbreviated new drug application (ANDA) of generic NITISONE for review

Chiasso, Switzerland, January 24th, 2019 – Dipharma S.A. (“Dipharma”) today announced that the U.S. Food and Drug Administration (FDA) accepted its...
Press
Dipharma SA
20 February 2019

Dipharma announces grant of centralised marketing authorization for generic Miglustat in Europe

Chiasso, Switzerland, February 20th, 2019 – – Dipharma S.A. (“Dipharma”) today announced that the European Commission has granted Marketing Authori...
Press
Dipharma SA
18 April 2018

Amerigen and Dipharma announce U.S. FDA approval for generic MIGLUSTAT 100 mg capsules

The first generic version of Miglustat is now approved in the U.S. Lyndhurst, N.J. and Chiasso, Switzerland. April 18th, 2018 – Amerigen Phar...
Press
Dipharma SA
23 February 2017

Dipharma announces the validation of DISANIT® (NITISONE) marketing authorization application in Europe

The first stable capsule formulation of Nitisinone for the treatment of hereditary Tyrosinemia type-1 (HT-1) is now under marketing authorization (...
Press
Dipharma SA
3 February 2017

DIPHARMA and ALVOGEN announce launch of Diterin® 100mg tablets in South Korea

First drug now registered and commercially available in the Republic of South Korea for the treatment of Hyperphenylalaninemia (HPA) due to Phenylk...
EnglishDeutsch